Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
To effectively counsel patients on contraception options, including long-acting reversible contraceptives (LARC), it is essential to ensure patient involvement and informed decision-making NICE CG30.
- Provide Comprehensive Information: Offer information on all contraceptive methods, including LARC, to enable an informed choice NICE CG30,NICE CKS. This information should be both verbal and written, tailored to the individual's needs, and presented in easily understandable language and formats NICE CG30,NICE CKS. Key details to cover include:
- Contraceptive efficacy NICE CG30,NICE CKS.
- Duration of use NICE CG30.
- How each method works NICE CKS.
- Risks and possible side effects NICE CG30,NICE CKS.
- Non-contraceptive benefits NICE CG30.
- The procedure for initiation and removal or discontinuation NICE CG30.
- When to seek help while using the method NICE CG30.
- Possible drug interactions NICE CKS.
- Health risks and benefits of the methods NICE CKS.
- Information on return to fertility after discontinuing the methods NICE CKS.
- Conduct a Thorough Assessment: Before initiating any contraceptive method, a medical history should be taken, including relevant family, menstrual, contraceptive, and sexual history NICE CG30,NICE CKS. Pregnancy must be excluded NICE CG30,NICE CKS. Assess the patient's suitability for different methods by identifying factors such as comorbidities, allergies, lifestyle, reproductive history, drug treatments, and age NICE CKS. Utilise nationally agreed guidance like the UK Medical Eligibility Criteria (UKMEC) to ensure safe use of methods NICE CG30,NICE CKS.
- Ensure Sensitivity and Accessibility: Counselling should be sensitive to cultural differences and religious beliefs NICE CG30. For patients who are not English speaking, or have sensory impairments or learning disabilities, ensure access to trained interpreters or advocates NICE CG30.
- Address Special Considerations:
- Young People: Be aware of the law regarding advice and contraception for young people, considering child protection issues and Fraser guidelines for those under 16 years NICE CG30,NICE. All methods can be considered, but avoid regular hormonal contraception in sexually active girls who have not started menstruating NICE CKS.
- Patients on Teratogenic Drugs: Advise the use of highly effective contraception, such as LARC methods (progestogen-only implant, copper intrauterine device, levonorgestrel intrauterine device), to reduce pregnancy risk NICE CKS.
- Patients on Liver Enzyme-Inducing Drugs: Advise on potential interactions with hormonal contraception and offer reliable methods unaffected by enzyme-inducers (Cu-IUD, LNG-IUD, progestogen-only injectable) NICE CKS.
- Post-Pregnancy/Abortion: Discuss contraception options with pregnant women for postnatal use, providing information on effective methods tailored to their needs NICE. For young women post-abortion, discuss contraception as soon as possible, dispelling myths about fertility immediately after NICE.
- Patients with Learning/Physical Disabilities: Support them in making their own decisions about contraception NICE CG30. If unable to understand, establish a care plan with carers and involved parties NICE CG30.
- Promote Safer Sex: Always promote safer sex, assess the risk for sexually transmitted infections (STIs), advise testing when appropriate, and provide information about local STI services NICE CG30.
- Provide Interim Contraception: If required, supply an interim method of contraception at the first appointment NICE CG30.